BioWorld

May 16, 2003

Genentech's Asthma Product, Xolair, Receives FDA Panel Nod

An FDA advisory panel said Xolair appears to work well enough in moderate to severe allergic asthmatic patients to win regulatory approval. (BioWorld Today) Read More

ID Biomedical Plans $22M Public Financing For Clinical Pipeline

Anglo-German Team Announces Genetic Molecular Basis Of Motor Neuron Diseases, Especially ALS

Chromos Enters Licensing Deal With CAT For Antibody Work

Other News To Note

U.S. Patent Disclosures

Today's news in brief

BioWorld

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

Astellas’ ASP-2246 shows promise in stroke management

BioWorld Science

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...